HIV-Aids Training
- Description
- Curriculum
- Grade
Learning Outcomes
Online HIV-Aids Training
Upon successful completion of this course, learners will be able to learn about-
v Etiology and Epidemiology of HIV/AIDS
v Origin and Strains of HIV
v Disease Pathogenesis
v HIV/AIDS in the United States
v HIV/AIDS in the Washington State
v Transmission Routes of HIV
v Possible Causes of HIV Transmission
v Factors that Increase Risk of Transmission
v Populations and Behaviors at Higher Risk
v Risk Reduction Methods
v Occupational Exposure to Bloodborne Pathogens
v Occupational Exposure to HIV/HBV/HCV and Other Bloodborne Pathogens
v Procedures for Homes and Home-like Settings
v Safe and Legal Disposal of Sharps
v CDC and Washington State Testing Recommendations
v Types of HIV Tests
v Getting Tested for HIV
v HIV Counseling
v Risk Assessment and Harm Reduction Strategies
v Natural History of HIV Infection
v Patient Management and Care
v Impact of New Drugs on Clinical Progression
v Managing Coexisting Infections
v Ongoing Management of HIV-Infected Patients
v Confidentiality
v Informed Consent
v HIV Reporting Requirements
v Behaviors Endangering the Public Health
v Psychosocial Impacts
v Neuropsychiatric Effects of HIV/AIDS
v How does HIV affect Special Populations
-
1Module 01: Etiology and Epidemiology of HIV/AIDS
-
2Lesson-1: Definition of HIV and AIDS
HIV is a virus that weakens and destroys the immune system over time, leaving infected individuals vulnerable to infections and diseases that would normally pose no threat to healthy people. In its most severe stage, known as AIDS, the infection becomes life-threatening, and while medical treatment can delay its progression, there is currently no cure for HIV or AIDS.
-
3Lesson-2: Origin and Strains of HIV
HIV-1, the most prevalent strain of the virus, was traced back to a subspecies of chimpanzees in West Equatorial Africa and is believed to have entered the human population through hunters' contact with infected blood before spreading globally. HIV is classified into two main types (HIV-1 and HIV-2), with HIV-1 further divided into multiple groups and subtypes that vary in prevalence, transmissibility, and response to treatment, making strain identification important for effective medical care.
-
4Lesson-3: Disease Pathogenesis
HIV targets and destroys T-helper (CD4) cells, which are essential for signaling antibody production and coordinating the immune response, ultimately leaving the body unable to defend against infections and diseases. The infection progresses through five stages—from an initial acute infection through an asymptomatic latency period that can last years, eventually advancing to symptomatic illness and full-blown AIDS when CD4 counts drop below 200, a process that typically takes about 10 years without antiretroviral treatment.
-
5Lesson-4: HIV/AIDS in the United States
HIV continues to disproportionately affect certain populations in the United States, with men who have sex with men (MSM) accounting for 71% of new diagnoses in 2020, and Black/African American and Hispanic/Latino communities bearing a significantly higher burden relative to their share of the population. An estimated 1.2 million people in the U.S. are living with HIV, with about 13% unaware of their status, and while overall incidence declined 8% between 2015 and 2019, achieving viral suppression through antiretroviral therapy remains critical both for individual health and for preventing transmission.
-
6Lesson-5: HIV/AIDS in the Washington State
In 2020, Washington State had an estimated 14,303 people living with HIV, with 421 new diagnoses that year, the majority being males aged 25-34, and male-to-male sexual contact serving as the predominant transmission category for both existing and newly diagnosed male cases. Significant racial disparities persist, with Black women being 23 times more likely than White women to receive an HIV diagnosis, and while 88% of those living with HIV were receiving medical care, the virus continues to disproportionately impact communities of color across the state.
-
7Etiology and Epidemiology of HIV/AIDS - Quiz 1
-
8Module-02: Transmission of HIV
-
9Lesson-1: Transmission Routes of HIV
-
10Lesson-2: Other Possible Causes of HIV Transmission
-
11Lesson-3: Factors that Increase Risk of Transmission
-
12Lesson-4: Populations and Behaviors at Higher Risk
-
13Transmission of HIV
-
14Module-03: Preventive and Control Measures
-
15Lesson-1: Risk Reduction Methods
-
16Lesson-2: Occupational Exposure to Bloodborne Pathogens
-
17Lesson-3: Occupational Exposure to HIV/HBV/HCV and Other Bloodborne Pathogens
-
18Lesson-4: Procedures for Homes and Home-like Settings
-
19Lesson-5: Safe and Legal Disposal of Sharps
-
20Preventive and Control Measures
-
21Module 04: HIV Testing and Counseling
-
22Lesson-1: CDC and Washington State Testing Recommendations
-
23Lesson-2: Types of HIV Tests
-
24Lesson-3: Getting Tested for HIV
-
25Lesson-4: HIV Counseling
-
26Lesson-5: Risk Assessment and Harm Reduction Strategies
-
27Testing and Counseling
-
28Module 05: Clinical Manifestations and Treatment of HIV and AIDS
-
29Lesson-1: Natural History of HIV Infection
-
30Lesson-2: Patient Management and Care
-
31Lesson-3: Impact of New Drugs on Clinical Progression
-
32Lesson-4: Managing Coexisting Infections
-
33Lesson-5: Ongoing Management of HIV-Infected Patients
-
34Clinical Manifestations and Treatment of HIV and AIDS
-
35Module 06: Legal and Ethical Issues
-
36Lesson-1: Confidentiality
-
37Lesson-2: Informed Consent
-
38Lesson-3: HIV Reporting Requirements
-
39Lesson-4: Behaviors Endangering the Public Health
-
40Legal and Ethical Issues
-
41Module 07: Psychosocial and Mental Health Issues
-
42Lesson-1: Psychosocial Impacts
-
43Lesson-2: Neuropsychiatric Effects of HIV/AIDS
-
44Lesson-3: Affecting Special Populations
-
45Psychosocial and Mental Health Issues
-
46Conclusion
